What is Cullinan Therapeutics Inc (CGEM)?
Cullinan Therapeutics Inc is a biopharmaceutical company dedicated to the development of targeted therapies for cancer treatment. The company focuses on creating antibody-drug conjugates and other biologics designed to selectively target tumor cells while minimizing effects on healthy tissues. Cullinan Therapeutics applies advanced molecular engineering and drug delivery technologies in its research and development processes. Its pipeline includes candidates addressing various oncology indications. The company collaborates with research institutions and industry partners to advance its therapeutic programs. It operates within the biotechnology industry, aiming to improve outcomes for patients with cancer.
Cullinan Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by market activity, with Wix.com Ltd priced at $12.8583. It fluctuates between $12.4617 and $13.6917 during the session, showing a daily change of +1.0243%.
FAQ: Cullinan Therapeutics Inc (CGEM)
What is the current price of CGEM stock?
Cullinan Therapeutics Inc is currently priced at $12.8583.
Does CGEM pay dividends?
Cullinan Therapeutics Inc does not pay dividends.
Does CGEM have a formal corporate presence or regional headquarters in the UAE?
Cullinan Therapeutics Inc operates in the UAE through partners and distributors only.
What is CGEM best known for?
The company is most famous for its development of targeted cancer therapies.
What assets are typically shown together with CGEM?
Commonly shown alongside CGEM: Legence Corp., Icahn Enterprises LP, AO World plc
Latest shares articles



